The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
2011 Falsified Medicines Directive (FMD) presentations from ESM and EDQM on implementation
Presentations on the Falsified Medicines Directive.
The 2011 Falsified Medicines Directive requires EU Member States to implement systems to ensure the verification and authentification of medicines by 2017/18.
Two systems are currently in development to deliver this:
• The European Stakeholder Model (a collaboration between EFPIA, PGEU, EAEPC and GIRP);
• EDQM’s E-tact system
Community pharmacies are expected to conduct a bar code scan of the secondary package of medicines at the point of dispensing to check its authenticity.
Similar requirements are envisaged for hospital pharmacy, but it is still unclear WHEN in the process between delivery and administration that this might take place i.e. when the medicine arrives into the hospital pharmacy; when the medicine leaves the hospital pharmacy; or close to when the medicine is administered to the patient.
2013 GA discussion was inconclusive with an apparent resolution to simply permit each country to interpret the Directive as it believes appropriate.
The meeting provides an opportunity for EAHP Board Members to become better informed about the potential opportunities and threats from implementation of this Directive, and best next steps for EAHP to take in relation to the Directive.
The meeting also provides an opportunity for EAHP to inform the specification and project teams of EDQM and ESM about the key needs and working environment in hospital pharmacy.
Some opportunity also exists to promote bar coding to the single unit, with reference as well to care home/residential home use and potential patient scanning with smartphones.